Arena Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 11 - 20 of about 79   

Articles published

ARNA 6.16 -0.18 (-2.84%)
price chart
Investor's Watch List - Inovio Pharmaceuticals Inc (INO), Arena ...
Stamford, Connecticut - 23th April 2014 - (Techsonian) - Inovio Pharmaceuticals Inc (NYSEMKT:INO), recently declared the appointment of E.J.
Trader's Buzzers- Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), MBIA Inc ...
Las Vegas, NV - April 23, 2014 - (TechSonian) - Arena Pharmaceuticals, Inc. (ARNA) reported that Eisai Inc. has launched a national television advertising campaign for BELVIQ� (lorcaserin HCl), an FDA-approved prescription treatment for chronic weight ...
Arena Pharmaceuticals Reports Eisai's Launch of National Television ...
SAN DIEGO, April 14, 2014 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) today reported that Eisai Inc. has launched a national television advertising campaign for BELVIQ � (lorcaserin HCl), an FDA-approved prescription treatment for ...
Arena Pharma (ARNA) Reports Launch of National Belviq Ad Campaign  StreetInsider.com (subscription)
Related articles »  
Arena - Belviq Sales Up Modestly Heading Into Television Ads
It is certainly an interesting time to be an investor in Arena Pharmaceuticals (ARNA). The company is about 10 months into its launch of the anti-obesity drug Belviq and the equity has taken several lumps along the way.
Related articles »  
Arena Script Sales Close Out Quarter On Positive Note
Sales of the Arena Pharmaceuticals (ARNA) anti-obesity drug Belviq have closed out the quarter on a positive note. Sales improved throughout the quarter and are pacing well ahead of the previous quarter.
What Arena's Belviq Television Ad Campaign Means For The Stock
The weight loss drug Belviq from Arena Pharmaceuticals (ARNA) is now being promoted on television with a national advertising campaign.
Sizzling News - Halcon Resources (NYSE:HK), Arena Pharmaceuticals, Inc ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) provided a corporate update and reported financial results for the fourth quarter and fiscal year which ended on December 31, 2013.
Stocks Buzz-Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), IAMGOLD Corp ...
Las Vegas, NV - April 22, 2014 - (TechSonian) �Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) provided a corporate update and reported financial results for the fourth quarter and fiscal year which ended on December 31, 2013.
News Recap: Arena Pharmaceuticals, Inc. (ARNA), IAMGOLD Corp (USA) (IAG ...
Manhattan, NY- April 22, 2014 - (Techsonian) - Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) provided a corporate update and reported financial results for the fourth quarter and fiscal year which ended on December 31, 2013.
Related articles »  
Biotech Active runners: Arena Pharmaceuticals (NASDAQ:ARNA), Halozyme ...
Sales of the Arena Pharmaceuticals Inc (NASDAQ:ARNA) anti-obesity drug Belviq have closed out the quarter on a positive note.
Traders Buzz: Arena Pharmaceuticals, Inc. (NASDAQ: ARNA), Alcoa Inc (NYSE ...  Market News Call
Biotech Active Movers: Arena Pharmaceuticals (NASDAQ:ARNA), EXACT ...  eFinance Hub
Related articles »